|
L3MBTL3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.713800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.483600E-01 |
| Normal-vs-Stage2 |
4.807600E-01 |
| Normal-vs-Stage3 |
7.996400E-02 |
| Normal-vs-Stage4 |
9.113400E-01 |
| Stage1-vs-Stage2 |
6.502600E-01 |
| Stage1-vs-Stage3 |
2.374000E-01 |
| Stage1-vs-Stage4 |
6.618600E-01 |
| Stage2-vs-Stage3 |
7.451000E-01 |
| Stage2-vs-Stage4 |
5.253200E-01 |
| Stage3-vs-Stage4 |
2.183600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.373200E-01 |
| Normal-vs-AfricanAmerican |
5.219200E-01 |
| Normal-vs-Asian |
3.092600E-01 |
| Caucasian-vs-AfricanAmerican |
3.377600E-01 |
| Caucasian-vs-Asian |
1.418570E-01 |
| AfricanAmerican-vs-Asian |
9.472200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.489800E-01 |
| Normal-vs-Female |
3.396800E-01 |
| Male-vs-Female |
8.763200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.409600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.979200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.992200E-02 |
| Normal-vs-Age(81-100Yrs) |
2.698100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.311800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.486600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.506950E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.053800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.267980E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.221200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.800900E-04 |
| Classical-VS-Follicular |
1.458640E-03 |
| Classical-VS-Other |
3.616100E-02 |
| Classical-VS-Normal |
5.359000E-01 |
| Tall-VS-Follicular |
6.441800E-01 |
| Tall-VS-Other |
4.801000E-01 |
| Tall-VS-Normal |
5.844300E-03 |
| Follicular-VS-Other |
7.591400E-01 |
| Follicular-VS-Normal |
7.275400E-03 |
| Other-VS-Normal |
2.008200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.735900E-02 |
| Normal-vs-N1 |
4.721200E-01 |
| N0-vs-N1 |
1.078150E-01 |
|
|
